First Human Egg Cells Grown From Stem Cells in Lab, Opening New Era for Fertility

The central claim of the new era in reproductive biology arrived not with a surgical procedure, but with a simple blood draw. In early July 2026, the California-based biotechnology startup Conception announced it had successfully generated the world's first early-stage human egg cells—known as primary oocytes—entirely from stem cells.

This milestone marks the most significant leap to date in a field known as in vitro gametogenesis (IVG), a process that aims to manufacture functional human reproductive cells outside the human body. By bypassing the ovaries entirely, the development provides the first concrete evidence that human biology's most fundamental limit—the finite ovarian reserve—might eventually be engineered away.[2][3][7]

The evidence for this breakthrough rests on a complex, multi-stage cellular reprogramming process that mimics human embryonic development. According to the primary data released by Conception, researchers began by isolating standard human blood cells and exposing them to a specific cocktail of transcription factors.

This exposure forced the adult cells to undergo "molecular amnesia," reverting them into induced pluripotent stem cells (iPSCs)—blank-slate cells capable of differentiating into nearly any tissue type in the human body. While creating iPSCs is a well-established technique, the critical innovation was what the research team managed to do next.[1][3][4]

To coax these blank-slate cells into becoming eggs, the researchers had to recreate the exact biochemical environment of a human ovary. The team guided a subset of the iPSCs to become primordial germ cells—the direct precursors to eggs—while turning another subset into ovarian helper cells. When cultured together, these cells self-organized into three-dimensional "mini-ovaries" or organoids. Within these lab-grown structures, the cells formed "oogonia nests," specialized boundary layers where future egg cells stay connected in chains, perfectly mirroring the structural development of a natural human ovary.[1][3][4]

Deep learning models comparing these stem-cell-derived follicles against reference atlases of natural human ovarian development confirmed the fidelity of the lab-grown cells. The biological markers indicated that the cells had successfully entered meiosis, the specialized form of cell division required to halve the number of chromosomes for sexual reproduction. Reaching this primary oocyte stage entirely in vitro is a world first for human cells, providing strong evidence that the complex signaling pathways required for human gamete formation can be artificially sustained.[2][3][4]

The foundation for this human evidence pack was laid a decade earlier in animal models. In 2016, Katsuhiko Hayashi, a developmental geneticist at the University of Osaka and a collaborator on the Conception project, successfully demonstrated IVG in mice.

Hayashi's team converted mouse skin cells into iPSCs, grew them into viable eggs, and fertilized them to produce healthy pups that went on to have litters of their own. However, translating this success from mice to humans proved exceptionally difficult due to the vastly different timelines and complex signaling requirements of human ovarian tissue.[1][3][4]

Prior to this stem-cell breakthrough, the closest scientists had come to artificial human eggs relied on a different, more limited mechanism. In late 2025, researchers at Oregon Health & Science University (OHSU) published evidence that they could create functional human eggs using somatic cell nuclear transfer—the same technique used to clone Dolly the sheep. The OHSU team stripped the nucleus from a donated human egg and replaced it with the nucleus of a skin cell, coaxing the hybrid cell to expel half its chromosomes.[5][8]

While the OHSU method successfully produced eggs capable of forming early embryos, it carried a significant limitation: it still required a steady supply of donated, hollowed-out human eggs to act as the incubator for the skin cell's DNA. The new IVG approach demonstrated by Conception is fundamentally different. Because it relies entirely on stem cells derived from blood, it does not require donor eggs at any stage of the process, making it infinitely scalable in theory.[3][7][8]

The clinical implications of this evidence are profound, promising to completely rewrite the landscape of fertility medicine. If the process can be safely matured, it would eliminate the need for the grueling hormone injections and invasive surgical egg retrievals that currently define in vitro fertilization (IVF). A patient could simply provide a blood sample, and a laboratory could generate as many healthy eggs as needed.[2][3][7]

This capability would offer unprecedented options for populations currently locked out of genetic parenthood. Women who have experienced premature ovarian failure, patients who lost their fertility to aggressive cancer treatments, and women who wish to have children well past the natural onset of menopause could all generate their own viable eggs. Furthermore, the underlying cellular mechanics suggest that stem cells from a male donor could theoretically be coaxed into becoming egg cells, potentially allowing same-sex male couples to have children genetically related to both partners.[1][7][8]

Despite the strength of the early-stage evidence, transparent uncertainty remains regarding the final maturation of these cells. The primary oocytes generated in the lab are not yet capable of being fertilized. The most significant remaining hurdle is growing these stem-cell-derived follicles from the primordial stage to the final "antral" stage—the point at which an egg is fully mature and ready for fertilization. While Conception has previously achieved this final maturation step using donated human tissue, proving that stem-cell-derived eggs can successfully navigate this final gauntlet remains an open question.[2][3]

Safety evaluations represent another massive area of uncertainty. The threshold for clinical use in human reproduction is extraordinarily high. Researchers must definitively prove that the artificial reprogramming process does not introduce chromosomal abnormalities or dangerous epigenetic mutations—alterations in how genes are turned on and off. Because these cells undergo "molecular amnesia" and are then artificially instructed to become eggs, any error in the epigenetic coding could result in severe developmental disorders in the resulting embryos.[2][6]

The regulatory and ethical landscape surrounding IVG is equally complex, as detailed in recent policy briefings by the UK Government and international bioethics panels. The ability to generate an unlimited supply of human eggs from a blood draw removes the primary biological bottleneck in embryo creation. This could enable the mass production of embryos for extensive genetic screening, allowing prospective parents to select embryos based on a wide array of traits, raising profound ethical questions about eugenics and the commodification of human life.[1][6]

Furthermore, an unlimited supply of eggs would make heritable human genome editing far more practical. Currently, the scarcity of human eggs makes experimental gene editing highly risky and inefficient. With an infinite supply of stem-cell-derived eggs, researchers could easily test and refine CRISPR edits to eliminate hereditary diseases—or introduce novel traits—before fertilization even occurs.[1][6]

For now, the scientific community is treating the development with a mix of awe and cautious optimism. The evidence clearly demonstrates that the biological barriers to creating human eggs from adult cells are engineering problems, not insurmountable laws of nature. As researchers work to push these early-stage oocytes to full maturity, the conversation will inevitably shift from whether we can manufacture human life in a laboratory, to how society will choose to govern the power to do so.[1][3][4][6]